Complementary and alternative medicine therapies for perinatal depression

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 28, Issue 1, 2014, Pages 85-95

  Deligiannidis, Kristina M ^a,b   Freeman, Marlene P ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acupuncture; Alternative; Bright light therapy; Complementary; Exercise; Massage; Omega 3 fatty acids; Perinatal depression; S adenosyl methionine; St. John's Wort; Treatment

Indexed keywords

FOLIC ACID; HYPERICUM PERFORATUM EXTRACT; OMEGA 3 FATTY ACID; PLACEBO; S ADENOSYLMETHIONINE;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ARTICLE; BRIGHT LIGHT THERAPY; DEPRESSION; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; EDINBURGH POSTNATAL DEPRESSION SCALE; EXERCISE; HEALTH PROMOTION; HUMAN; HYPERICUM PERFORATUM; MASSAGE; META ANALYSIS; MOOD DISORDER; NEURAL TUBE DEFECT; PERINATAL DEPRESSION; PHOTOTHERAPY; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); THERAPY EFFECT;

ACUPUNCTURE; ALTERNATIVE; BRIGHT LIGHT THERAPY; COMPLEMENTARY; EXERCISE; MASSAGE; OMEGA-3 FATTY ACIDS; PERINATAL DEPRESSION; S-ADENOSYL-METHIONINE; ST. JOHN'S WORT; TREATMENT;

ACUPUNCTURE THERAPY; COMPLEMENTARY THERAPIES; DEPRESSION; DEPRESSION, POSTPARTUM; DIETARY SUPPLEMENTS; EXERCISE; FATTY ACIDS, OMEGA-3; FEMALE; FOLIC ACID; HUMANS; HYPERICUM; MASSAGE; MOTHERS; PERIPARTUM PERIOD; PHOTOTHERAPY; PREGNANCY; S-ADENOSYLMETHIONINE;

EID: 84891630466     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2013.08.007     Document Type: Article

References (97)

1. Blazer DG, Kessler RC, McGonagle KA, et al. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994;151:979-86.
2. Gavin NI, Gaynes BN, Lohr KN, et al. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005;106(5 Pt 1):1071-83.
3. Bodnar LM, Wisner KL, Moses-Kolko E, et al. Prepregnancy body mass index, gestational weight gain, and the likelihood of major depressive disorder during pregnancy. J Clin Psychiatry 2009;70:1290-6.
4. Britton JR. Infant temperament and maternal anxiety and depressed mood in the early postpartum period. Women Health 2011;51:55-71.
5. Chung TK, Lau TK, Yip AS, et al. Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosom Med 2001;63:830-4.
6. Cripe SM, Frederick IO, Qiu C, et al. Risk of preterm delivery and hypertensive disorders of pregnancy in relation to maternal co-morbid mood and migraine disorders during pregnancy. Paediatr Perinat Epidemiol 2011;25:116-23.
7. Grote NK, Bridge JA, Gavin AR, et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010;67:1012-24.
8. Jablensky AV, Morgan V, Zubrick SR, et al. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005;162:79-91.
9. Gotlib IH, Whiffen VE, Wallace PM, et al. Prospective investigation of postpartum depression: factors involved in onset and recovery. J Abnorm Psychol 1991;100:122-32.
10. Forman DR, O'Hara MW, Stuart S, et al. Effective treatment for postpartum depression is not sufficient to improve the developing mother-child relationship. Dev Psychopathol 2007;19:585-602.
11. Deave T, Heron J, Evans J, et al. The impact of maternal depression in pregnancy on early child development. BJOG 2008; 115:1043-51.
12. Lindahl V, Pearson JL, Colpe L. Prevalence of suicidality during pregnancy and the postpartum. ArchWomens Ment Health 2005;8:77-87.
13. Bishop JL, Northstone K, Green JR, et al. The use of complementary and alternative medicine in pregnancy: data from the Avon Longitudinal Study of Parents and Children (ALSPAC). Complement Ther Med 2011;19:303-10.
14. Wu P, Fuller C, Liu X, et al. Use of complementary and alternative medicine among women with depression: results of a national survey. Psychiatr Serv 2007;58:349-56.
15. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2009;12:1-23.
16. Hibbeln JR, Davis JM, Steer C, et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 2007;369:578-85.
17. McGregor JA, Allen KG, Harris MA, et al. The omega-3 story: nutritional prevention of preterm birth and other adverse pregnancy outcomes. Obstet Gynecol Surv 2001;56:S1-13.
18. Koletzko B, Lien E, Agostoni C, et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 2008;36:5-14.
19. Scientific Advisory Committee on Nutrition and Committee on Toxicity. Advice on fish consumption: benefits and risks. London, United Kingdom: The Stationary Office; 2004.
20. Cetin I, Koletzko B. Long-chain omega-3 fatty acid supply in pregnancy and lactation. Curr Opin Clin Nutr Metab Care 2008;11:297-302.
21. EFSA Panel on Dietetic Products, Nutrition, and Allergies. Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J 2010;8:1461.
22. Freeman MP. Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research. Prostaglandins Leukot Essent Fatty Acids 2006;75:291-7.
23. Su KP, Huang SY, Chiu CC, et al. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebocontrolled trial. Eur Neuropsychopharmacol 2003;13:267-71.
24. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002;159:477-9.
25. Kumar R, Robson KM. A prospective study of emotional disorders in childbearing women. Br J Psychiatry 1984;144:35-47.
26. Freeman MP, Hibbeln JR, Wisner KL, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006;67:1954-67.
27. Golding J, Steer C, Emmett P, et al. High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology 2009;20:598-603.
28. Browne JC, Scott KM, Silvers KM. Fish consumption in pregnancy and omega-3 status after birth are not associated with postnatal depression. J Affect Disord 2006;90:131-9.
29. Strom M, Mortensen EL, Halldorsson TI, et al. Fish and long-chain n-3 polyunsaturated fatty acid intakes during pregnancy and risk of postpartum depression: a prospective study based on a large national birth cohort. Am J Clin Nutr 2009; 90:149-55.
30. Rees AM, Austin MP, Parker GB. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. Aust N Z J Psychiatry 2008;42:199-205.
31. Freeman MP, Davis M, Sinha P, et al. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J Affect Disord 2008;110:142-8.
32. Doornbos B, van Goor SA, Dijck-Brouwer DA, et al. Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33:49-52.
33. Makrides M, Gibson RA, McPhee AJ, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010;304:1675-83.
34. Su KP, Huang SY, Chiu TH, et al. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2008;69:644-51.
35. Freeman MP, Hibbeln JR, Wisner KL, et al. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2006;113:31-5.
36. Freeman MP, Hibbeln JR, Wisner KL, et al. An open trial of omega-3 fatty acids for depression in pregnancy. Acta Neuropsychiatr 2006;18:21-4.
37. Kendrick T, Dunn N, Robinson S, et al. A longitudinal study of blood folate levels and depressive symptoms among young women in the Southampton Women's Survey. J Epidemiol Community Health 2008;62:966-72.
38. Watanabe H, Ishida S, Konno Y, et al. Impact of dietary folate intake on depressive symptoms in young women of reproductive age. J Midwifery Womens Health 2012;57:43-8.
39. Nguyen PH, Grajeda R, Melgar P, et al. Micronutrient supplementation may reduce symptoms of depression in Guatemalan women. Arch Latinoam Nutr 2009;59:278-86.
40. Papakostas GI, Petersen T, Mischoulon D, et al. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry 2004;65:1090-5.
41. Alpert M, Silva RR, Pouget ER. Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant. J Clin Psychopharmacol 2003;23:309-13.
42. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord 2000;60:121-30.
43. Papakostas GI, Shelton RC, Zajecka JM, et al. L-Methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry 2012;169:1267-74.
44. Inskip HM, Crozier SR, Godfrey KM, et al. Women's compliance with nutrition and lifestyle recommendations before pregnancy: general population cohort study. BMJ 2009;338:b481.
45. Grosse SD, Collins JS. Folic acid supplementation and neural tube defect recurrence prevention. Birth Defects Res A Clin Mol Teratol 2007;79:737-42.
46. Miyake Y, Sasaki S, Tanaka K, et al. Dietary folate and vitamins B12, B6, and B2 intake and the risk of postpartum depression in Japan: the Osaka Maternal and Child Health Study. J Affect Disord 2006;96:133-8.
47. Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr 2002;76:1158S-61S.
48. Bressa GM. S-adenosyl-L-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand Suppl 1994;154:7-14.
49. Hardy M, Coulter I, Morton SC, et al. S-adenosyl-L-methionine (SAMe) for depression, osteoarthritis and liver disease. Rockville, MD: Agency for Healthcare Research and Quality; August 2002.
50. Papakostas GI, Mischoulon D, Shyu I, et al. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry 2010;167:942-8.
51. Levkovitz Y, Alpert JE, Brintz CE, et al. Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder. J Affect Disord 2012;136:1174-8.
52. Cerutti R, Sichel MP, Perin M, et al. Psychological distress during the puerperium: a novel therapeutic approach using Sadenosylmethionine. Curr Ther Res 1993;53:701-16.
53. Linde K, Mulrow CD, Berner M, et al. St John's wort for depression. Cochrane Database Syst Rev 2005:CD000448.
54. Roder C, Schaefer M, Leucht S. Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort [in German]. Fortschr Neurol Psychiatr 2004;72:330-43.
55. Murphy PA, Kern SE, Stanczyk FZ, et al. Interaction of St John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception 2005;71: 402-8.
56. Rayburn WF, Christensen HD, Gonzalez CL. Effect of antenatal exposure to Saint John's wort (Hypericum) on neurobehavior of developing mice. Am J Obstet Gynecol 2000;183:1225-31.
57. Dugoua JJ, Mills E, Perri D, et al. Safety and efficacy of St. John's wort (hypericum) during pregnancy and lactation. Can J Clin Pharmacol 2006;13:e268-76.
58. Gregoretti B, Stebel M, Candussio L, et al. Toxicity of Hypericum perforatum (St John's wort) administered during pregnancy and lactation in rats. Toxicol Appl Pharmacol 2004;200:201-5.
59. Moretti ME, Maxson A, Hanna F, et al. Evaluating the safety of St. John's Wort in human pregnancy. Reprod Toxicol 2009; 28:96-9.
60. Klier CM, Schmid-Siegel B, Schafer MR, et al. St John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants. J Clin Psychiatry 2006;67:305-9.
61. Lee A, Minhas R, Matsuda N, et al. The safety of St John's wort (Hypericum perforatum) during breastfeeding. J Clin Psychiatry 2003;64:966-8.
62. Wileman SM, Eagles JM, Andrew JE, et al. Light therapy for seasonal affective disorder in primary care: randomised controlled trial. Br J Psychiatry 2001;178:311-6.
63. Eastman CI, Young MA, Fogg LF, et al. Bright light treatment of winter depression: a placebo-controlled trial. Arch Gen Psychiatry 1998;55:883-9.
64. Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 2005;162:656-62.
65. Sit D, Wisner KL, Hanusa BH, et al. Light therapy for bipolar disorder: a case series in women. Bipolar Disord 2007;9:918-27.
66. Oren DA,Wisner KL, Spinelli M, et al. An open trial of morning light therapy for treatment of antepartum depression. Am J Psychiatry 2002;159:666-9.
67. Epperson CN, Terman M, Terman JS, et al. Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings. J Clin Psychiatry 2004;65:421-5.
68. Wirz-Justice A, Bader A, Frisch U, et al. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry 2011;72:986-93.
69. Corral M, Wardrop AA, Zhang H, et al. Morning light therapy for postpartum depression. Arch Womens Ment Health 2007;10:221-4.
70. Krogh J, Nordentoft M, Sterne JA, et al. The effect of exercise in clinically depressed adults: systematic review and metaanalysis of randomized controlled trials. J Clin Psychiatry 2010;72:529-38.
71. Mota-Pereira J, Silverio J, Carvalho S, et al. Moderate exercise improves depression parameters in treatment-resistant patients with major depressive disorder. J Psychiatr Res 2011;45:1005-11.
72. Strawbridge WJ, Deleger S, Roberts RE, et al. Physical activity reduces the risk of subsequent depression for older adults. Am J Epidemiol 2002;156:328-34.
73. Chalder M, Wiles NJ, Campbell J, et al. A pragmatic randomised controlled trial to evaluate the cost-effectiveness of a physical activity intervention as a treatment for depression: the treating depression with physical activity (TREAD) trial. Health Technol Assess 2012;16(10):1-164 iii-iv.
74. Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. BMJ 2001;322:763-7.
75. Artal R, O'Toole M. Guidelines of the American College of Obstetricians and Gynecologists for exercise during pregnancy and the postpartum period. Br J Sports Med 2003;37:6-12.
76. Bell BB, Dooley MP. Exercise in pregnancy (RCOG Statement 4). Royal College of Obstetricians and Gynaecologists; 2006.
77. Robledo-Colonia AF, Sandoval-Restrepo N, Mosquera-Valderrama YF, et al. Aerobic exercise training during pregnancy reduces depressive symptoms in nulliparous women: a randomised trial. J Physiother 2012;58:9-15.
78. Da Costa D, Rippen N, Dritsa M, et al. Self-reported leisure-time physical activity during pregnancy and relationship to psychological well-being. J Psychosom Obstet Gynaecol 2003;24:111-9.
79. Songoygard KM, Stafne SN, Evensen KA, et al. Does exercise during pregnancy prevent postnatal depression? A randomized controlled trial. Acta Obstet Gynecol Scand 2011;91:62-7.
80. Norman E, Sherburn M, Osborne RH, et al. An exercise and education program improves well-being of new mothers: a randomized controlled trial. Phys Ther 2010;90:348-55.
81. Heh SS, Huang LH, Ho SM, et al. Effectiveness of an exercise support program in reducing the severity of postnatal depression in Taiwanese women. Birth 2008;35:60-5.
82. Armstrong K, Edwards H. The effects of exercise and social support on mothers reporting depressive symptoms: a pilot randomized controlled trial. Int J Ment Health Nurs 2003;12:130-8.
83. Dritsa M, Da Costa D, Dupuis G, et al. Effects of a home-based exercise intervention on fatigue in postpartum depressed women: results of a randomized controlled trial. Ann Behav Med 2008;35:179-87.
84. Field T, Hernandez-Reif M, Diego M, et al. Cortisol decreases and serotonin and dopamine increase following massage therapy. Int J Neurosci 2005;115:1397-413.
85. Hou WH, Chiang PT, Hsu TY, et al. Treatment effects of massage therapy in depressed people: a meta-analysis. J Clin Psychiatry 2010;71:894-901.
86. Field T, Diego MA, Hernandez-Reif M, et al. Massage therapy effects on depressed pregnant women. J Psychosom Obstet Gynaecol 2004;25:115-22.
87. Field T, Figueiredo B, Hernandez-Reif M, et al. Massage therapy reduces pain in pregnant women, alleviates prenatal depression in both parents and improves their relationships. J Bodyw Mov Ther 2008;12:146-50.
88. Field T, Diego M, Hernandez-Reif M, et al. Pregnancy massage reduces prematurity, low birthweight and postpartum depression. Infant Behav Dev 2009;32:454-60.
89. Field T, Diego M, Hernandez-Reif M, et al. Yoga and massage therapy reduce prenatal depression and prematurity. J Bodyw Mov Ther 2012;16:204-9.
90. Field T, Deeds O, Diego M, et al. Benefits of combining massage therapy with group interpersonal psychotherapy in prenatally depressed women. J Bodyw Mov Ther 2009;13:297-303.
91. Quah-Smith I, Smith C, Crawford JD, et al. Laser acupuncture for depression: a randomised double blind controlled trial using low intensity laser intervention. J Affect Disord 2013;48:179-87.
92. Andreescu C, Glick RM, Emeremni CA, et al. Acupuncture for the treatment of major depressive disorder: a randomized controlled trial. J Clin Psychiatry 2011;72:1129-35.
93. Smith CA, Hay PP, Macpherson H. Acupuncture for depression. Cochrane Database Syst Rev 2010;(1):CD004046.
94. Gaudet LM, Dyzak R, Aung SK, et al. Effectiveness of acupuncture for the initiation of labour at term: a pilot randomized controlled trial. J Obstet Gynaecol Can 2008;30:1118-23.
95. Manber R, Schnyer RN, Allen JJ, et al. Acupuncture: a promising treatment for depression during pregnancy. J Affect Disord 2004;83:89-95.
96. Manber R, Schnyer RN, Lyell D, et al. Acupuncture for depression during pregnancy: a randomized controlled trial. Obstet Gynecol 2010;115:511-20.
97. Chung KF, Yeung WF, Zhang ZJ, et al. Randomized non-invasive sham-controlled pilot trial of electroacupuncture for postpartum depression. J Affect Disord 2012;142:115-21.